C07C201/16

METHOD FOR OPERATING A DISTILLATION COLUMN
20230008804 · 2023-01-12 ·

The present invention relates to a method for continuously operating a distillation column, which is designed to separate a mixture S, which contains essentially a substance A and a substance B, which boils significantly higher than substance A. In the method according to the invention, the reflux ratio is changed according to the feed flow and, at the same time, the energy input by means of the heat-transfer medium is changed proactively (so-called feed-forward control) by accounting for the feed flow by means of feed-forward control. At the same time, the bottom temperature is observed and the control structure is changed if the bottom temperature falls too far when the heat-transfer medium is reduced by means of the feed flow.

METHOD FOR OPERATING A DISTILLATION COLUMN
20230008804 · 2023-01-12 ·

The present invention relates to a method for continuously operating a distillation column, which is designed to separate a mixture S, which contains essentially a substance A and a substance B, which boils significantly higher than substance A. In the method according to the invention, the reflux ratio is changed according to the feed flow and, at the same time, the energy input by means of the heat-transfer medium is changed proactively (so-called feed-forward control) by accounting for the feed flow by means of feed-forward control. At the same time, the bottom temperature is observed and the control structure is changed if the bottom temperature falls too far when the heat-transfer medium is reduced by means of the feed flow.

METHOD FOR OPERATING A DISTILLATION COLUMN
20230008804 · 2023-01-12 ·

The present invention relates to a method for continuously operating a distillation column, which is designed to separate a mixture S, which contains essentially a substance A and a substance B, which boils significantly higher than substance A. In the method according to the invention, the reflux ratio is changed according to the feed flow and, at the same time, the energy input by means of the heat-transfer medium is changed proactively (so-called feed-forward control) by accounting for the feed flow by means of feed-forward control. At the same time, the bottom temperature is observed and the control structure is changed if the bottom temperature falls too far when the heat-transfer medium is reduced by means of the feed flow.

PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES
20220363619 · 2022-11-17 ·

The present invention provides a process for purifying a monoterpene or sesquiterpene having a purity greater than about 98.5% (w/w). The process comprises the steps of derivatizing the monoterpene (or sesquiterpene) to produce a monoterpene (or sesquiterpene) derivative, separating the monoterpene (or sesquiterpene) derivative, and releasing the monoterpene (or sesquiterpene) from the derivative. Also encompassed by the scope of the present invention is a pharmaceutical composition comprising a monoterpene (or sesquiterpene) having a purity greater than about 98.5% (w/w). The purified monoterpene can be used to treat a disease such as cancer. The present monoterpene (or sesquiterpene) may be administered alone, or may be co-administered with radiation or other therapeutic agents, such as chemotherapeutic agents.

PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES
20220363619 · 2022-11-17 ·

The present invention provides a process for purifying a monoterpene or sesquiterpene having a purity greater than about 98.5% (w/w). The process comprises the steps of derivatizing the monoterpene (or sesquiterpene) to produce a monoterpene (or sesquiterpene) derivative, separating the monoterpene (or sesquiterpene) derivative, and releasing the monoterpene (or sesquiterpene) from the derivative. Also encompassed by the scope of the present invention is a pharmaceutical composition comprising a monoterpene (or sesquiterpene) having a purity greater than about 98.5% (w/w). The purified monoterpene can be used to treat a disease such as cancer. The present monoterpene (or sesquiterpene) may be administered alone, or may be co-administered with radiation or other therapeutic agents, such as chemotherapeutic agents.

PROCESS FOR THE PRODUCTION OF ANTITUMOUR PHARMACEUTICAL COMPOSITIONS USING PUSH-PULL BUTADIENES, COMPOUNDS AND USES THEREOF

The present invention reports the obtaining of carbonyl compounds and derivatives, through syntheses with high yield and purity, providing anti-humoral active principles with selective antiproliferative properties and anti-metastatic activity.

The present invention refers to the development of new polyfunctional push-pull butadienes and their O and C-prenylated, benzoylated and iodide derivatives, with high electronic conjugation in the lateral chain. These compounds exhibit high anti-tumor selectivity, causing cell death by apoptosis, also show anti-metastatic and non-mutagenic properties in the experimental studies performed.

PROCESS FOR THE PRODUCTION OF ANTITUMOUR PHARMACEUTICAL COMPOSITIONS USING PUSH-PULL BUTADIENES, COMPOUNDS AND USES THEREOF

The present invention reports the obtaining of carbonyl compounds and derivatives, through syntheses with high yield and purity, providing anti-humoral active principles with selective antiproliferative properties and anti-metastatic activity.

The present invention refers to the development of new polyfunctional push-pull butadienes and their O and C-prenylated, benzoylated and iodide derivatives, with high electronic conjugation in the lateral chain. These compounds exhibit high anti-tumor selectivity, causing cell death by apoptosis, also show anti-metastatic and non-mutagenic properties in the experimental studies performed.

PROCESS FOR THE PREPARATION OF A-METHYL-[4-(NITRO)-2-(TRIFLUOROMETHYL) -BENZYL NITRATE

The present invention relates to a process for the preparation of α-methyl-[4-(nitro)-2-(trifluoromethyl)]-benzyl nitrate and to the α-methyl-[4-(nitro)-2-(trifluoromethyl)]-benzyl nitrate.

PROCESS FOR THE PREPARATION OF A-METHYL-[4-(NITRO)-2-(TRIFLUOROMETHYL) -BENZYL NITRATE

The present invention relates to a process for the preparation of α-methyl-[4-(nitro)-2-(trifluoromethyl)]-benzyl nitrate and to the α-methyl-[4-(nitro)-2-(trifluoromethyl)]-benzyl nitrate.

EXHAUST GAS CLEANING IN A METHOD FOR CONTINUOUSLY PRODUCING DINITROTOLUENE

The invention relates to a method for producing dinitrotoluene, comprising the following steps: a) nitrating toluene with a mixture of nitric acid and sulfuric acid and subsequently separating a sulfuric-acid-containing aqueous phase that arises in the nitration, wherein a raw dinitrotoluene is obtained, b) washing the raw dinitrotoluene in a water wash with neutral and/or alkaline washing water, wherein a pre-cleaned dinitrotoluene, which contains at least water in addition to dinitrotoluene, is obtained after the washing water used in the last wash has been separated, and c) separating the water from the pre-cleaned dinitrotoluene, d) collecting the waste water from steps a), b), and/or c), e) optionally extracting the collected waste water from step d) with toluene and returning the thus obtained organic phase to step a), f) freeing the collected waste water from step d), or, if the optional step e) is performed, the extracted waste water from step e), of toluene in a toluene stripper, wherein a toluene-containing exhaust gas flow is obtained, g) feeding at least one exhaust gas flow from steps a), b), c), d), e), or f) into an exhaust gas condenser and removing the toluene contained in the at least one exhaust gas flow in said exhaust gas condenser, wherein the method comprises the following further step: h) feeding the exhaust gas flow arising in step g) after the condensing out of the toluene to a thermal exhaust air cleaning, wherein nitrogen is added to the exhaust gas flow to be fed to the exhaust gas condenser or to the exhaust gas flow leaving the exhaust gas condenser, wherein preferably a nitrogen concentration in the exhaust gas flow of at least 0.1 vol % is set, especially preferably of at least 0.5 vol %.